PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL

Clinical trial NCT06290622 · WITHDRAWN

Trial details

NCT number: NCT06290622
Sponsor: University of Alabama at Birmingham
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Lymphoma, B-Cell Lymphoma, Follicular

Start date: 2024-08-30
Primary completion: 2026-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.